Nabeel Bardeesy Selected Research

Circulating Neoplastic Cells

1/2019	Quasimesenchymal phenotype predicts systemic metastasis in pancreatic ductal adenocarcinoma.
9/2014	Single-cell RNA sequencing identifies extracellular matrix gene expression by pancreatic circulating tumor cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nabeel Bardeesy Research Topics

Disease

102	Neoplasms (Cancer) 03/2024 - 01/2002
23	Pancreatic Neoplasms (Pancreatic Cancer) 12/2023 - 06/2008
22	Cholangiocarcinoma 05/2024 - 04/2014
16	Adenocarcinoma 01/2022 - 06/2004
13	Lung Neoplasms (Lung Cancer) 04/2023 - 01/2008
12	Carcinogenesis 11/2019 - 10/2003
11	Neoplasm Metastasis (Metastasis) 04/2022 - 04/2006
7	Fibrosis (Cirrhosis) 01/2021 - 04/2014
6	Hypoxia (Hypoxemia) 01/2022 - 03/2008
5	Peutz-Jeghers Syndrome (Polyposis, Hamartomatous Intestinal) 01/2019 - 07/2004
4	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2024 - 01/2016
4	Disease Progression 10/2023 - 03/2010
4	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 04/2014
3	Melanoma (Melanoma, Malignant) 10/2023 - 05/2005
3	Liver Neoplasms (Liver Cancer) 01/2023 - 09/2014
3	Inflammation (Inflammations) 11/2014 - 07/2011
3	Polyps 02/2014 - 07/2004
2	Ovarian Neoplasms (Ovarian Cancer) 03/2023 - 01/2023
2	Carcinoma (Carcinomatosis) 01/2022 - 01/2008
2	Liver Diseases (Liver Disease) 01/2021 - 04/2014
2	Non-alcoholic Fatty Liver Disease 01/2021 - 01/2019
2	Tuberous Sclerosis (Bourneville's Disease) 01/2019 - 07/2004
2	Circulating Neoplastic Cells 01/2019 - 09/2014
2	Hypersensitivity (Allergy) 01/2016 - 08/2013
2	Mitochondrial Diseases (Mitochondrial Disease) 08/2015 - 12/2010
2	Liver Cirrhosis (Hepatic Cirrhosis) 08/2015 - 04/2014
2	Colonic Neoplasms (Colon Cancer) 03/2012 - 03/2006
1	Urinary Bladder Neoplasms (Bladder Cancer) 03/2024

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 12/2023 - 03/2006
13	RNA (Ribonucleic Acid)IBA 01/2023 - 06/2004
12	Phosphotransferases (Kinase)IBA 03/2024 - 03/2004
8	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022 - 01/2014
6	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2009
6	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 06/2004
6	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 04/2023 - 03/2004
5	Transcription Factors (Transcription Factor)IBA 10/2023 - 03/2008
5	Cyclin-Dependent Kinase Inhibitor p16IBA 07/2014 - 01/2002
4	infigratinibIBA 10/2023 - 01/2017
4	NAD (NADH)IBA 04/2023 - 06/2016
4	ChromatinIBA 01/2022 - 08/2009
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 01/2015
4	MicroRNAs (MicroRNA)IBA 01/2022 - 09/2011
4	Adenosine Triphosphate (ATP)IBA 12/2021 - 07/2004
4	AMP-Activated Protein KinasesIBA 01/2019 - 03/2004
4	alpha-hydroxyglutarateIBA 09/2014 - 01/2014
3	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 10/2009
3	Gemcitabine FDA Link 01/2024 - 04/2010
3	Cysteine (L-Cysteine)FDA Link 10/2023 - 01/2009
3	LigandsIBA 10/2023 - 01/2010
3	futibatinibIBA 10/2023 - 01/2019
3	CollagenIBA 01/2020 - 09/2012
3	Mechanistic Target of Rapamycin Complex 1IBA 12/2016 - 05/2010
3	Messenger RNA (mRNA)IBA 10/2016 - 01/2010
3	ErbB Receptors (EGF Receptor)IBA 04/2014 - 05/2005
3	NucleotidesIBA 08/2013 - 01/2009
3	Peptides (Polypeptides)IBA 09/2012 - 01/2009
3	Transforming Growth Factor beta (TGF-beta)IBA 07/2009 - 11/2006
3	Adenosine Monophosphate (AMP)IBA 02/2008 - 03/2004
2	Tyrosine Kinase InhibitorsIBA 03/2024 - 05/2015
2	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 01/2023
2	Cell-Free Nucleic AcidsIBA 12/2023 - 01/2017
2	Circulating Tumor DNAIBA 10/2023 - 01/2017
2	PlatinumIBA 03/2023 - 01/2023
2	ivosidenibIBA 09/2022 - 06/2021
2	CytokinesIBA 04/2022 - 07/2011
2	InterferonsIBA 01/2022 - 01/2019
2	EnzymesIBA 01/2022 - 01/2014
2	AlbuminsIBA 01/2021 - 12/2015
2	Contrast MediaIBA 01/2020 - 08/2010
2	folfirinoxIBA 01/2020 - 01/2018
2	Serine (L-Serine)FDA Link 11/2019 - 11/2016
2	Antiviral Agents (Antivirals)IBA 01/2019 - 11/2014
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2019 - 01/2017
2	Glutamine (L-Glutamine)FDA Link 01/2019 - 04/2013
2	trans-sodium crocetinate (crocetin)IBA 01/2019 - 07/2004
2	Sorafenib (BAY 43-9006)FDA Link 01/2017 - 05/2015
2	Polycomb Repressive Complex 2IBA 01/2017 - 01/2017
2	Mechanistic Target of Rapamycin Complex 2IBA 12/2016 - 01/2015
2	Sirolimus (Rapamycin)FDA Link 12/2016 - 03/2010
2	AntioxidantsIBA 10/2016 - 07/2011
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2016 - 07/2015
2	Carbon Tetrachloride (Tetrachloromethane)IBA 08/2015 - 04/2014
2	Oxygen (Dioxygen)IBA 06/2015 - 08/2010
2	Small Interfering RNA (siRNA)IBA 03/2015 - 03/2006
2	Hyaluronic Acid (Hyaluronan)IBA 07/2014 - 09/2012
2	Epidermal Growth Factor (EGF)IBA 04/2014 - 05/2005
2	Insulin (Novolin)FDA Link 03/2014 - 04/2009
2	Complementary DNA (cDNA)IBA 01/2014 - 06/2004
2	CateninsIBA 01/2013 - 03/2012
2	Metformin (Glucophage)FDA LinkGeneric 05/2010 - 12/2005
2	MTOR InhibitorsIBA 03/2010 - 07/2004
2	ProteomeIBA 01/2009 - 06/2008
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 05/2024
1	Apoptosis Regulatory ProteinsIBA 04/2024
1	HLA Antigens (Human Leukocyte Antigens)IBA 02/2024

Therapy/Procedure

30	Therapeutics 01/2024 - 03/2004
10	Drug Therapy (Chemotherapy) 01/2024 - 04/2010
5	Immunotherapy 01/2023 - 09/2012
3	Chemoprevention 01/2021 - 01/2014
2	Ligation 04/2014 - 01/2009